Urmăriți
Oana Barboi
Oana Barboi
Sef lucr, UMF Iasi
Adresă de e-mail confirmată pe umfiasi.ro
Titlu
Citat de
Citat de
Anul
Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies
DM Bunu, CE Timofte, M Ciocoiu, M Floria, CC Tarniceriu, OB Barboi, ...
Gastroenterology research and practice 2019, 2019
812019
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
E Savarino, F Zingone, B Barberio, G Marasco, F Akyuz, H Akpinar, ...
United European gastroenterology journal 10 (6), 556-584, 2022
572022
The role of diet in the overlap between gastroesophageal reflux disease and functional dyspepsia
I Chirila, ID Morariu, OB Barboi, VL Drug
Turk J Gastroenterol 27 (1), 73-80, 2016
532016
Artificial Intelligence in Digestive Endoscopy—Where are we and where are we going?
RA Vulpoi, M Luca, A Ciobanu, A Olteanu, OB Barboi, VL Drug
Diagnostics 12 (4), 927, 2022
172022
Discrete choice experiment reveals strong preference for dietary treatment among patients with irritable bowel syndrome
R Sturkenboom, D Keszthelyi, AAM Masclee, BAB Essers
Clinical Gastroenterology and Hepatology 20 (11), 2628-2637, 2022
152022
Effect of inulin in the treatment of irritable bowel syndrome with constipation
OB Bărboi, I Ciortescu, I Chirilă, C Anton, V Drug
Experimental and Therapeutic Medicine 20 (6), 1-1, 2020
132020
Novel Mutation in APC Gene Associated with Multiple Osteomas in a Family and Review of Genotype-Phenotype Correlations of Extracolonic Manifestations in …
C Antohi, D Haba, L Caba, ML Ciofu, VL Drug, OB Bărboi, BI Dobrovăț, ...
Diagnostics 11 (9), 1560, 2021
112021
Atrial fibrillation and gastro-oesophageal reflux disease-controversies and challenges
M Floria, O Barboi, C Rezus, V Ambarus, C Cijevschi-Prelipcean, G Balan, ...
Current Pharmaceutical Design 21 (26), 3829-3834, 2015
102015
Biliary hamartoma
OB Barboi, LG Moisii, A Albu-Soda±, I Ciortescu, V Drug
Medicine and Pharmacy Reports 86 (4), 383-384, 2013
102013
Atrial fibrillation and sympathovagal balance in patients with gastroesophageal reflux disease
M Floria, O Barboi, M Grecu, C Cijevschi Prelipcean, G Balan, VL Drug
Turk J Gastroenterol 28 (2), 88-93, 2017
92017
Gastroesophageal reflux disease in respiratory disorders
M Sandu, O Barboi, V Drug
Journal of Gastroenterology and Hepatology 28, 513-514, 2013
92013
Pepsin and the Lung—Exploring the Relationship between Micro-Aspiration and Respiratory Manifestations of Gastroesophageal Reflux Disease
DE Iov, OB Bărboi, M Floria, A Neamțu, R Iliescu, VL Drug
Journal of Personalized Medicine 12 (8), 1296, 2022
82022
Romanian guidelines for nonpharmacological therapy of IBS
C Brisc
J Gastrointestin Liver Dis 30 (2), 291-306, 2021
82021
How the Internet influences the relationship between outpatients and gastroenterologists: A multicenter study
VL Drug, I Chirila, A Albusoda, I Bancila, S Iordache, L Nedelcu, C Irina, ...
The Turkish Journal of Gastroenterology 31 (1), 17, 2020
82020
Functional bowel disorders with diarrhoea: clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United Eur …
E Savarino, F Zingone, B Barberio, G Marasco, F Akyuz, H Akpinar, ...
DOI: https://doi. org/10.1002/ueg2 12259, 556-584, 0
8
The tribes and tribulations of laryngopharyngeal reflux: a review of recent studies with implications for interdisciplinary collaborations between otolaryngologists and …
OB Barboi, C CIJEVSCHI-PRELIPCEAN, MD Cobzeanu, D Palade, ...
The Medical-Surgical Journal 119 (4), 967-973, 2015
72015
The biotics family: current knowledge and future perspectives in metabolic diseases
CM Palade, GA Vulpoi, RA Vulpoi, VL Drug, OB Barboi, M Ciocoiu
Life 12 (8), 1263, 2022
62022
Hereditary Hemorrhagic Telangiectasia and Arterio-Venous Malformations—From Diagnosis to Therapeutic Challenges
M Floria, ED Năfureanu, DE Iov, O Sîrbu, M Dranga, A Ouatu, DM Tănase, ...
Journal of Clinical Medicine 11 (9), 2634, 2022
62022
Romanian Guidelines for the Diagnosis and Treatment of GERD-induced Respiratory Manifestations.
VL Drug, S Antoniu, OB Bărboi, OC Arghir, I Băncilă, S Bățagă, C Brisc, ...
Journal of Gastrointestinal & Liver Diseases 31 (1), 2022
62022
The Potential Use of Artificial Intelligence in Irritable Bowel Syndrome Management
RA Vulpoi, M Luca, A Ciobanu, A Olteanu, O Bărboi, DE Iov, L Nichita, ...
Diagnostics 13 (21), 3336, 2023
52023
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20